期刊
BONE & JOINT JOURNAL
卷 103B, 期 2, 页码 234-244出版社
BRITISH EDITORIAL SOC BONE & JOINT SURGERY
DOI: 10.1302/0301-620X.103B2.BJJ-2020-0452.R2
关键词
-
资金
- Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [R15HD092931]
Antibiotic resistance poses a serious threat to human health, while phage therapy may provide an effective solution to antibiotic-resistant infections. Research in this area is beginning to show successful results, primarily in non-orthopaedic fields.
Antibiotic resistance represents a threat to human health. It has been suggested that by 2050, antibiotic-resistant infections could cause ten million deaths each year. In orthopaedics, many patients undergoing surgery suffer from complications resulting from implant-associated infection. In these circumstances secondary surgery is usually required and chronic and/or relapsing disease may ensue. The development of effective treatments for antibiotic-resistant infections is needed. Recent evidence shows that bacteriophage (phages; viruses that infect bacteria) therapy may represent a viable and successful solution. In this review, a brief description of bone and joint infection and the nature of bacteriophages is presented, as well as a summary of our current knowledge on the use of bacteriophages in the treatment of bacterial infections. We present contemporary published in vitro and in vivo data as well as data from clinical trials, as they relate to bone and joint infections. We discuss the potential use of bacteriophage therapy in orthopaedic infections. This area of research is beginning to reveal successful results, but mostly in nonorthopaedic fields. We believe that bacteriophage therapy has potential therapeutic value for implant-associated infections in orthopaedics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据